|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61K 9/14 | |||
| A61K 9/20 |
| (11) | Number of the document | 2276465 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09722765.6 |
| Date of filing the European patent application | 2009-03-18 | |
| (97) | Date of publication of the European application | 2011-01-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/001744 |
| Date | 2009-03-18 |
| (87) | Number | WO 2009/117130 |
| Date | 2009-09-24 |
| (30) | Number | Date | Country code |
| 70332 P | 2008-03-21 | US |
| (72) |
CHATTARAJ, Sarat, C., US
BHAT, Pavan, US
REDELMAN, Glenn, A., US
WARGO, David, J., US
ADDICKS, William, US
|
| (73) |
Mylan Pharmaceuticals, Inc.,
1311 Pineview Drive White Birch Tower II 5th Floor, Morgantown, WV 26505,
US
|
| (54) | Extended release formulation containing a wax |
| Extended release formulation containing a wax |